Aqr Capital Management LLC Durect Corp Transaction History

Aqr Capital Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$1.6 - $2.02 $31,436 - $39,688	-19,648 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$1.86 - $2.87 $125,635 - $193,857	-67,546 Reduced 77.47%	19,648 $39,000
Q4 2020 Feb 16, 2021	SELL	$1.65 - $2.43 $533,933 - $786,338	-323,596 Reduced 78.77%	87,194 $180,000
Q3 2020 Nov 16, 2020	BUY	$1.6 - $2.35 $657,264 - $965,356	410,790 New	410,790 $702,000
Q2 2019 Aug 14, 2019	SELL	$0.51 - $0.86 $33,888 - $57,146	-66,449 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$0.51 - $0.82 $53,908 - $86,676	-105,703 Reduced 61.4%	66,449 $42,000
Q4 2018 Feb 14, 2019	SELL	$0.48 - $1.1 $189,903 - $435,195	-395,632 Reduced 69.68%	172,152 $83,000
Q3 2018 Nov 15, 2018	BUY	$1.06 - $1.69 $505,521 - $805,972	476,907 Added 524.78%	567,784 $625,000
Q2 2018 Aug 14, 2018	BUY	$1.56 - $2.51 $141,768 - $228,101	90,877 New	90,877 $142,000

593K

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $175M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aqr Capital Management LLC with notifications on news.